STAAR-3 Clinical Study

NCT00369733 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

443

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Chronic Renal Insufficiency
Kidney Disease
Pre-dialysis
Pre-ESRD

Interventions

DRUG: Darbepoetin alfa

Sponsor

Amgen